- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ARX788 Cemiplimab
Total 163 results
-
Ambrx, Inc.WithdrawnHER2 Mutation-Related Tumors | HER2 Amplified Solid TumorsUnited States
-
Zhejiang Medicine Co., Ltd.Ambrx, Inc.TerminatedStomach Neoplasms | Breast NeoplasmsAustralia, New Zealand
-
Fudan UniversityRecruiting
-
Fudan UniversityRecruitingHER2-positive, Metastatic Breast CancerChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingStage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 | Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 | Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck | Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck | Stage...United States
-
Ottawa Hospital Research InstituteOntario Institute for Cancer ResearchNot yet recruiting
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingRecurrent Skin Squamous Cell Carcinoma | Resectable Skin Squamous Cell Carcinoma | Stage I Skin Cancer | Stage II Skin Cancer | Stage III Skin CancerUnited States
-
Regeneron PharmaceuticalsPacific Pediatric Neuro-Oncology ConsortiumTerminatedHigh Grade Glioma | Diffuse Intrinsic Pontine Glioma | Relapsed Solid Tumor | Refractory Solid Tumor | Relapsed Central Nervous System Tumor | Refractory Central Nervous System TumorUnited States
-
Regeneron PharmaceuticalsSanofiNo longer availableCutaneous Squamous Cell Carcinoma
-
H. Lee Moffitt Cancer Center and Research InstituteRegeneron PharmaceuticalsTerminatedCutaneous Squamous Cell Carcinoma of the Head and Neck | Cutaneous Squamous Cell CarcinomaUnited States
-
Regeneron PharmaceuticalsCompletedAdvanced Cutaneous Squamous Cell CarcinomaUnited States, Spain, France, Italy, Australia, Germany, Brazil, Greece
-
Regeneron PharmaceuticalsActive, not recruitingBasal Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States, Puerto Rico
-
Regeneron PharmaceuticalsSanofiCompletedCarcinoma, Basal CellUnited States, Canada, France, Italy, Spain, Germany, Belgium, Austria, Greece, Switzerland
-
Regeneron PharmaceuticalsSanofiCompletedMelanomaKorea, Republic of, Serbia, Netherlands, United Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedRecurrent Squamous Cell Carcinoma of Head | Recurrent Squamous Cell Carcinoma of Neck | Metastatic Squamous Cell Carcinoma of Head | Metastatic Squamous Cell Carcinoma NeckKorea, Republic of, United Kingdom
-
Reinhard DummerSanofi; Sun Pharmaceutical Industries LtdRecruiting
-
University of MiamiRegeneron PharmaceuticalsWithdrawnHead and Neck Squamous Cell Carcinoma | HNSCC | Squamous Cell Carcinoma of the Larynx | Squamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma of Hypopharynx
-
Regeneron PharmaceuticalsRecruitingAdvanced Solid Tumor | Metastatic Solid TumorNetherlands
-
Regeneron PharmaceuticalsSanofiActive, not recruitingMalignanciesUnited States, Korea, Republic of, Australia, Ireland, United Kingdom
-
Regeneron PharmaceuticalsNot yet recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteRegeneron Pharmaceuticals; Sanofi-SynthelaboRecruitingMerkel Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States
-
Dana-Farber Cancer InstituteAstellas Pharma Inc; Regeneron PharmaceuticalsActive, not recruiting
-
SanofiTerminatedMalignant Solid TumorFrance, Spain, Australia, Belgium, Italy, United Kingdom, Taiwan, Estonia, Netherlands, Korea, Republic of, United States, Canada, Germany
-
Regeneron PharmaceuticalsRecruitingRelapsed/Refractory Aggressive B-Cell LymphomaUnited States, Germany, Spain
-
Novartis PharmaceuticalsCompletedGlioblastoma MultiformeUnited States
-
Novartis PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsRecruitingRecurrent Endometrial Cancer | Recurrent Ovarian Cancer | Recurrent Fallopian Tube Cancer | Recurrent Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Italy, United Kingdom, Netherlands, Belgium, Australia, France, Israel
-
SanofiBioNTech RNA Pharmaceuticals GmbHTerminatedMetastatic NeoplasmFrance, Spain, United States, Belgium, Germany, Netherlands
-
Regeneron PharmaceuticalsSanofiRecruitingHepatocellular Carcinoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell CarcinomaUnited States
-
Peter MacCallum Cancer Centre, AustraliaSanofi; Regeneron Pharmaceuticals; Monash University; University of Adelaide; University...RecruitingNeoplasms | Cutaneous Squamous Cell Carcinoma of the Head and Neck | Non-melanoma Skin Cancer | Cutaneous Squamous Cell CarcinomaAustralia
-
Ambrx, Inc.CompletedBreast Neoplasms | Solid Tumors | Gastric NeoplasmUnited States, Australia
-
SanofiCompletedPlasma Cell MyelomaFrance, Italy, Czechia, Greece, Spain, Canada, Australia, United States, Brazil, Hungary
-
Regeneron PharmaceuticalsSanofiTerminatedNon-small Cell Lung CancerUnited States, Italy, Lithuania
-
SanofiTerminatedProstate Cancer | Non-small Cell Lung CancerTaiwan, United States, France, Italy, United Kingdom
-
Regeneron PharmaceuticalsRecruitingAdvanced Non-Small Cell Lung CancerKorea, Republic of, United States, Australia, Georgia
-
Regeneron PharmaceuticalsSanofiActive, not recruitingNon-small Cell Lung CancerUnited States, France, Korea, Republic of, Italy, Austria, China, Georgia, Greece, Ireland, Lithuania, Malaysia, Poland, Romania, Russian Federation, Slovakia, Thailand, Turkey, Ukraine
-
Laura Huppert, MD, BAAmbrx, Inc.Not yet recruitingARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast CancerTriple Negative Breast Cancer | Hormone Receptor Positive Breast Carcinoma | HER2 Low Breast Carcinoma | Hormone-receptor-positive Breast CancerUnited States
-
SanofiTerminatedLymphomaKorea, Republic of, Portugal, France, Taiwan, Italy, Netherlands, Spain
-
Ambrx, Inc.RecruitingHER2 Positive Metastatic Breast CancerUnited States, Korea, Republic of, France, Australia
-
Regeneron PharmaceuticalsRecruitingAdvanced Solid TumorsUnited States, Turkey
-
Regeneron PharmaceuticalsActive, not recruitingAdvanced Non-small Cell Lung CancerUnited States
-
Alaunos TherapeuticsCompleted
-
Emory UniversityNational Cancer Institute (NCI)RecruitingMetastatic Skin Squamous Cell Carcinoma | Recurrent Skin Squamous Cell CarcinomaUnited States
-
Regeneron PharmaceuticalsSuspendedNon-Small Cell Lung Cancer | Triple Negative Breast Cancer | Merkel Cell Carcinoma | Basal Cell Carcinoma | Oropharynx Squamous Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States, Australia
-
Regeneron PharmaceuticalsSanofiTerminatedAdvanced Non-Small Cell Lung CarcinomaUnited States, Belgium, France, Germany, Korea, Republic of, Poland, Spain, Taiwan, United Kingdom
-
Rakuten Medical, Inc.Active, not recruitingRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head-and-neck Squamous-cell Carcinoma | Metastatic Cutaneous Squamous Cell Carcinoma | Locally Advanced Cutaneous Squamous Cell CarcinomaUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyRecruitingNon-Small Cell Lung CancerKorea, Republic of, United States, Japan
-
Radboud University Medical CenterGenzyme Europe B.V.RecruitingMetastasis | Locally Advanced Sarcoma | Secondary AngiosarcomaNetherlands
-
BioNTech SETerminatedProstate CancerUnited States, Germany, United Kingdom, Hungary
-
Fondazione Melanoma OnlusActive, not recruitingCutaneous Squamous Cell CarcinomaItaly